The 5 BILLION Reason Alpine Immune Sciences Stock Is Up 30 percent Today
| CGRIX Fund | USD 72.72 0.08 0.11% |
Slightly above 55% of Calamos Growth's investor base is interested to short. The analysis of overall sentiment of trading Calamos Growth Fund mutual fund suggests that many investors are impartial at this time. Calamos Growth's investing sentiment can be driven by a variety of factors including economic data, Calamos Growth's earnings reports, geopolitical events, and overall market trends.
Calamos |
Vertex hopes Alpines drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Read at investorplace.com
 |
Calamos Growth Fundamental Analysis
We analyze Calamos Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calamos Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calamos Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Calamos Growth is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Calamos Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calamos Growth mutual fund to make a market-neutral strategy. Peer analysis of Calamos Growth could also be used in its relative valuation, which is a method of valuing Calamos Growth by comparing valuation metrics with similar companies.
Peers
Calamos Growth Related Equities
| SROCX | Calamos Antetokounmpo | 0.32 | ||||
| SROIX | Calamos Antetokounmpo | 0.31 | ||||
| CVAAX | Calamos Opportunistic | 0.22 | ||||
| CVACX | Calamos Opportunistic | 0.21 | ||||
| CVGCX | Calamos Growth | 0.12 | ||||
| CVLCX | Calamos Global | 0.09 | ||||
| CVLOX | Calamos Global | 0.08 | ||||
| CVGRX | Calamos Growth | 0.11 | ||||
| CVAIX | Calamos Opportunistic | 0.21 | ||||
| SRORX | Calamos Antetokounmpo | 0.39 |
Other Information on Investing in Calamos Mutual Fund
Calamos Growth financial ratios help investors to determine whether Calamos Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Calamos with respect to the benefits of owning Calamos Growth security.
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |